Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model

QR Code

Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model

Enterovirus 71 (EV71) is one of the causative agents of the hand, foot and mouth disease (HFMD) in human. Outbreaks of HFMD may lead to severe pathogenesis in young children and infants worldwide. Children below 5 years of age are more susceptible to severe forms of HFMD which are associated with ne...

Full description

Bibliographic Details
Main Author:	Mustafa, Suhaili
Format:	Thesis
Language:	English
Published:	2017
Subjects:	Enterovirus diseases Immunity
Online Access:	http://psasir.upm.edu.my/id/eprint/70078/ http://psasir.upm.edu.my/id/eprint/70078/1/FBSB%202017%201%20-%20IR.pdf

Similar Items

Factors affecting expression and solubility of Enterovirus 71 VP1 protein
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)

Protective Efficacy Evaluation of NPt-NPt-VP1₁₋₁₀₀Protein as a Candidate Vaccine Against Enterovirus 71 Infections in Mouse Model
by: Ch'ng, Wei Choong
Published: (2010)

Development of human enterovirus 71 nano calcium phosphate adjuvanted candidate vaccine for parenteral and mucosal delivery
by: Saeed Ahmed, Mohamed Ibrahim
Published: (2015)

Immunogenicity of a truncated enterovirus 71 VP1 protein fused to a Newcastle disease virus nucleocapsid protein fragment in mice.
by: Ch'ng, Wei Choong, et al.
Published: (2011)

The Nucleocapsid Protein Of Newcastle Disease Virus As A Carrier For The Vp1 Polypeptides Of Enterovirus 71
by: Sivasamugham, Lalita Ambigal
Published: (2005)

Construction Of Recombinant Bcg Expressing The Vp1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine
by: Othman, Nurulhasanah
Published: (2006)

Immunogenicity study of dna vaccine and dna vaccine carrier expressing vp1 of enterovirus 71 in the prime boost vaccination strategy
by: Nur Ayuni, Kadir
Published: (2008)

Inhibition of Enterovirus 71 (EV-71 infections by a novel antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)

Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant newcastle disease virus capsids displaying the EV71 VP1 fragment.
by: Wei, Choong Ch'ng, et al.
Published: (2011)

High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1
by: Tan, Cheng Siang, et al.
Published: (2007)

Molecular Epidemiology of Human Enterovirus 71 Strains and Recent Outbreaks in the Asia-Pacific Region: Comparative Analysis of the VP1 and VP4 Genes
by: Cardosa, Mary Jane, et al.
Published: (2003)

Construction Of Recombinant BCG Expressing The VP1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine [QR186.87. N974 2007 f rb]
by: Othman, Nurulhasanah
Published: (2006)

The Aetiology of Hand, Foot and Mouth Disease in Western Australia and the Northern Territory, 2007-2010
by: Williams, David, et al.
Published: (2011)

Recombinant human enterovirus 71 in hand, foot and mouth disease patients
by: Yoke, Fun Chan, et al.
Published: (2004)

A comparison of the VP1, VP2, and VP4 regions for molecular typing of human enteroviruses
by: Perera, D., et al.
Published: (2010)

The expression of recombinant bacille calmette-guerin (rBCG) containing VPI gene of enterovirus 71 (EV71)
by: Wey, Goh Kai
Published: (2008)

A decade of sustained selection pressure on two surface sites of the VP1 protein of Enterovirus A71 suggests that immune evasion may be an indirect driver for virulence
by: Roberts, Ryan, et al.
Published: (2019)

Improvement of the Solubility of the Vp2 Hypervariable Region of Infectious Bursal Disease Virus by Fusion to the NP Protein of Newcastle Disease Virus
by: Saadun, Rafidah
Published: (2005)

Identification of mimotopes of human enterovirus 71
by: Yee, Siew Fung.
Published: (2007)

Solution structure of a novel T-cell adhesion inhibitor derived from the fragment of ICAM-1 receptor: cyclo(1,8)-Cys-Pro-Arg-Gly-Gly-Ser-Val-Cys
by: Tejo, Bimo Ario, et al.
Published: (2009)

Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)

Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)

Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)

Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)

Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)

Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
by: Calvo-Pinilla, Eva, et al.
Published: (2018)

The ecology of immune variation in wild house mice (Mus musculus domesticus)
by: Young, Stuart
Published: (2019)

Beta-actin variant is necessary for Enterovirus 71 replication
by: Lui, Edmund Yan Long, et al.
Published: (2013)

Impact of genetic changes in the Enterovirus 71 genome on virulence
by: Poh, Chit Laa *, et al.
Published: (2019)

Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)

Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)

Generation of endogenous soluble PD-1 as a potential therapeutic strategy for cancer treatment
by: Wahid, Mussarat
Published: (2019)

IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
by: Jackaman, Connie, et al.
Published: (2014)

Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
by: David, Perera, et al.
Published: (2004)

Molecular docking of SP40 peptide towards cellular receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)

Production of a Recombinant Vp1 Protein of the Chicken Anaemiavirus for the Development of an Enzyme-Linked Immunosorbent Assay
by: Mahgoub, Elhem Omer
Published: (2004)

Potential usefulness of viral capsid surface proteins (VP1,VP2, VP3 & VP4) for vaccination against common cold
by: Alshrari, Ahmed Subeh D
Published: (2016)

Solubility, Immunogenicity and Physical Properties Of the Nucleocapsid Protein of Nipah Virus Produced in Escherichia Coli.
by: Wen, Siang Tan, et al.
Published: (2004)

Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)